Apogee Therapeutics (APGE) Current Assets (2022 - 2026)
Apogee Therapeutics (APGE) posted Current Assets of $991.73 million for Q2 2026, up 92.2% from $516.12 million a year earlier but down 7.6% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Apogee Therapeutics' Current Assets came in at $741.36 million, up 40.0% from FY2024.
- Annual Current Assets has increased for three consecutive years, with a three-year compound annual growth rate of 69.6% (FY2022 to FY2025).
- In prior years, Apogee Therapeutics' Current Assets was $529.71 million in FY2024 (+33.0%), $398.41 million in FY2023 (+162.0%) and $152.06 million in FY2022.
- Quarterly Current Assets has run from a low of $130.67 million in Q2 2023 to a high of $1.07 billion in Q1 2026 over five years.
- On a year-over-year basis, Current Assets has increased in each of the last four quarters, with growth averaging 29.6% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q2 2024, with growth of 421.8%; the weakest was Q1 2025, with a decline of 36.4%.
- According to Business Quant data, Current Assets for the three prior quarters was $1.07 billion (Q1 2026), $741.36 million (Q4 2025) and $540.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 991.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 991.73 Mn |
| Mar 31, 2026 | 1.07 Bn |
| Dec 31, 2025 | 741.36 Mn |
| Sep 30, 2025 | 540.10 Mn |
| Jun 30, 2025 | 516.12 Mn |
| Mar 31, 2025 | 521.53 Mn |
| Dec 31, 2024 | 529.71 Mn |
| Sep 30, 2024 | 534.48 Mn |
| Jun 30, 2024 | 681.85 Mn |
| Mar 31, 2024 | 820.61 Mn |
| Dec 31, 2023 | 398.41 Mn |
| Sep 30, 2023 | 426.42 Mn |
| Jun 30, 2023 | 130.67 Mn |
| Dec 31, 2022 | 152.06 Mn |
API Access
Apogee Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();